LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 65.12 | 17.25 | 2906 | 5095 | 0.5703 | 0.8677 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 65.12 | 17.25 | 1310 | 5095 | 0.2571 | 0.6949 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 65.12 | 17.25 | 3978 | 5095 | 0.7807 | 0.9406 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 67.09 | 17.25 | 3 | 5221 | 0.0006 | -0.1912 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 67.09 | 17.25 | 3026 | 5221 | 0.5796 | 0.8719 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 67.09 | 17.25 | 1252 | 5221 | 0.2398 | 0.6818 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 67.09 | 17.25 | 4241 | 5221 | 0.8123 | 0.9502 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 69.06 | 17.25 | 1 | 5242 | 0.0002 | -0.2920 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 69.06 | 17.25 | 3213 | 5242 | 0.6129 | 0.8847 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 69.06 | 17.25 | 1555 | 5242 | 0.2966 | 0.7260 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 69.06 | 17.25 | 4438 | 5242 | 0.8465 | 0.9600 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.03 | 17.25 | 1 | 5367 | 0.0002 | -0.2910 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.03 | 17.25 | 3376 | 5367 | 0.6290 | 0.8911 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.03 | 17.25 | 1578 | 5367 | 0.2940 | 0.7252 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.03 | 17.25 | 4649 | 5367 | 0.8662 | 0.9656 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.00 | 17.25 | 2 | 5546 | 0.0004 | -0.2280 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.00 | 17.25 | 3558 | 5546 | 0.6414 | 0.8962 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.00 | 17.25 | 1444 | 5546 | 0.2603 | 0.7016 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.00 | 17.25 | 4839 | 5546 | 0.8724 | 0.9675 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 74.97 | 17.25 | 1 | 5618 | 0.0002 | -0.2891 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 74.97 | 17.25 | 3716 | 5618 | 0.6613 | 0.9034 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 74.97 | 17.25 | 1542 | 5618 | 0.2744 | 0.7130 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 74.97 | 17.25 | 5042 | 5618 | 0.8973 | 0.9742 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.94 | 17.25 | 1 | 5681 | 0.0002 | -0.2886 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.94 | 17.25 | 3936 | 5681 | 0.6928 | 0.9141 | MN20160310_N02 | D16 |